Recent Patents on Novel P2X7 Receptor Antagonists Potentially Effective for Treatment of Inflammatory Diseases

E-ISSN： 2210-3104|3|1|1-24

ISSN： 2210-3090

Source： Recent Patents on Biomarkers, Vol.3, Iss.1, 2013-01, pp. : 1-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C terminus of the P2X7 receptor: treasure hunting

By Costa-Junior Helio

Purinergic Signalling, Vol. 7, Iss. 1, 2011-03 ,pp. : 7-19

Springer Publishing Company

Access to resources Recommend Favorite

Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion: Presented by: Maria P. Abbracchio

By Wang Ning Gartland Alison

Purinergic Signalling, Vol. 9, Iss. 3, 2013-09 ,pp. : 281-284

Springer Publishing Company

Access to resources Recommend Favorite

Astroglial P2X7 receptor current density increased following long-term exposure to rotenone

By Gao Xiao-Fei

Purinergic Signalling, Vol. 7, Iss. 1, 2011-03 ,pp. : 65-72

Springer Publishing Company

Access to resources Recommend Favorite

P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells

By Gadeock Safina

Purinergic Signalling, Vol. 8, Iss. 4, 2012-12 ,pp. : 669-676

Springer Publishing Company

Access to resources Recommend Favorite

CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation

By Pupovac A. Stokes L. Sluyter R.

Purinergic Signalling, Vol. 9, Iss. 4, 2013-12 ,pp. : 609-619

Springer Publishing Company

Access to resources Recommend Favorite